Recent Company News

• 05:15 AM ET Dec 15, 2025
  

  Intron Health upgrades NOVN.SW, UCB.BB; downgrades GSK.LN

• 06:59 AM ET Dec 08, 2025
  

  Insurance, industrials/defense, healthcare the best performers; food/beverage, personal/household goods and autos/arts main laggards:

• 02:54 AM ET Dec 05, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:17 AM ET Dec 08, 2025
  

  UCB presents positive results from GEMZ phase 3 study at the American Epilepsy Society (AES) meeting (€247.50, 0.00)

• 08:51 AM ET Dec 05, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:54 AM ET Dec 05, 2025
  

  Autos, healthcare, financial services best performers; energy, insurance and real estate lag:

• 04:46 AM ET Dec 05, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:12 AM ET Dec 05, 2025
  

  UCB upgrades FY25 financial guidance amidst robust year to date performance (€239.90, 0.00)

• 01:07 AM ET Dec 04, 2025
  

  UCB will present 21 abstracts at the American Epilepsy Society (AES) Annual Meeting 5-9 Dec (€239.80, 0.00)